Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation
- Status
- COMPLETED
- Phase
- NA
Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy
- Status
- COMPLETED
- Phase
- NA
A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
- Status
- UNKNOWN
- Phase
- PHASE2
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"
- Status
- COMPLETED
- Phase
- N/A
Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Surgical Therapy and Survival in HCC/ C.F. Zhang et al.
- Status
- COMPLETED
- Phase
- N/A
PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation
- Status
- COMPLETED
- Phase
- N/A
Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）
- Status
- UNKNOWN
- Phase
- PHASE2
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
- Status
- COMPLETED
- Phase
- NA
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2